Human tryptophanyl-tRNA synthetase (hTrpRS) produces a full-length and three N terminus-truncated forms through alternative splicing and proteolysis. The shortest fragment that contains the aminoacylation catalytic fragment (T2-hTrpRS) exhibits the most potent angiostatic activity. We report here the crystal structure of T2-hTrpRS at 2.5 Å resolution, which was solved using the multi-wavelength anomalous diffraction method. T2-hTrpRS shares a very low sequence homology of 22% with Bacillus stearothermophilus TrpRS (bTrpRS); however, their overall structures are strikingly similar. Structural comparison of T2-hTrpRS with bTrpRS reveals substantial structural differences in the substratebinding pocket and at the entrance to the pocket that play important roles in substrate binding and tRNA binding. T2-hTrpRS has a wide opening to the active site and adopts a compact conformation similar to the closed conformation of bTrpRS. These results suggest that mammalian and bacterial TrpRSs might use different mechanisms to recognize the substrate. Modeling studies indicate that tRNA binds with the dimeric enzyme and interacts primarily with the connective polypeptide 1 of hTrpRS via its acceptor arm and the ␣-helical domain of hTrpRS via its anticodon loop. Our results also suggest that the angiostatic activity is likely located at the ␣-helical domain, which resembles the short chain cytokines.
In humans, there are 19 cytoplasmic aaRSs; one of them (glutamyl-prolyl-tRNA synthetase) is bifunctional. In addition to aminoacylation activity, some aaRSs from higher eukaryotes have new functions that are not observed in enzymes from prokaryotic and lower eukaryotic organisms. These new functions were often acquired by the addition of extra domain(s) to the aminoacylation catalytic domain during the evolution process (7) (8) (9) . Human tryptophanyl-tRNA synthetase (hTrpRS) (EC 6.1.1.2) contains an extra domain of about 150 residues at its N terminus that is absent in prokaryotic TrpRSs (10 -12) . Alternative splicing produces two forms of hTrpRS in human cells: full-length hTrpRS (residues 1-471) and mini-hTrpRS (residues 48 -471) (10, 11) . Proteolytic hydrolysis of the fulllength enzyme with extracellular protease produces two additional N terminus-truncated fragments: T1-hTrpRS (residues 71-471) and T2-hTrpRS (residues 94 -471) (13, 14) . Although the full-length, mini-, and T1-hTrpRS possess aminoacylation activity, T2-hTrpRS does not (10, 13, 14) . On the other hand, the mini-, T1-, and T2-hTrpRS are shown to have angiostatic activity in signal pathways of angiogenesis, whereas the fulllength enzyme is inactive (13, 14) . In particular, T2-hTrpRS, which lacks most of the N-terminal domain acts as the most potent, dose-dependent antagonist of angiogenesis in vivo and inhibits the endothelial cell activation stimulated by vascular endothelial growth factor in vitro.
Similarly human tyrosyl-tRNA synthetase (hTyrRS) has acquired an extra C-terminal domain (about 170 residues) that is not found in TyrRSs from lower eukaryotes, archebacteria, or prokaryotes (15) . Alternative splicing or proteolysis generates two biologically functional fragments. The N-terminal fragment (mini-hTyrRS) has both the aminoacylation activity and an interleukin-8-like cytokine activity and acts as a proangiogenic factor (16, 17) . The extra C-terminal domain is a homolog of endothelial monocyte-activating polypeptide II and has a cytokine-like activity in leukocytes and monocytes (18) . The full-length hTyrRS, however, has only aminoacylation activity.
So far, all known structures of aaRSs are from bacteria or yeast, except the recently reported structures of the N-terminal fragment and the C-terminal domain of hTyrRS (17, 18) . Although structures of TrpRS from Bacillus stearothermophilus (bTrpRS) in either unliganded form or in complexes with ATP, Trp, and Trp-5Ј AMP (TAM) have been determined (19 -21) , there is no reported structure for any mammalian TrpRS. Because the sequence homology between bacterial and mammalian TrpRSs is very limited, structural studies of hTrpRS will provide a molecular basis about the mechanism of aminoacylation by mammalian aaRSs. The structural information might also provide insights into the activation of its angiogenic activity.
We report here the crystal structure of the aminoacylation catalytic fragment of hTrpRS (T2-hTrpRS) at 2.5 Å resolution, which was determined using the multi-wavelength anomalous diffraction (MAD) method. Although hTrpRS has a very low sequence homology of 22% with bTrpRS, the two enzymes share a similar overall structure. Structural comparison of hTrpRS with bTrpRS reveals unique structural features of hTrpRS that are related to its specificity and tRNA binding. Analysis of the structure also allows us to suggest the potential site(s) for the angiostatic activity.
EXPERIMENTAL PROCEDURES
Expression, Purification, and Crystallization of hTrpRS-The expression and purification of hTrpRS were carried out as described previously (22) . Selenium-methionine-substituted hTrpRS was expressed in Escherichia coli strain B834 (DE3) (Novagen) and purified using the same methods as for the native protein. Full-length hTrpRS consists of 471 amino acids. Crystallization was performed using the hanging drop method with equal volumes of the protein solution (2 l) and the reservoir solution (2 l), and 0.5 l of 30% 2-methyl-2,4-pentanediol. Crystals used for diffraction data collection were grown from a protein solution containing 8 mg/ml hTrpRS in a buffer (20 mM K 2 HPO 4 , pH 6.8, 10 mM MgCl 2 , and 5 mM 2-mercaptoethanol). The reservoir solution contains 16% (w/v) polyethylene glycol 1500, 4% polyethylene glycol 3350, and 0.2 M trisodium citrate dihydrate, pH 8.2. Crystals of hTrpRS grew to approximately a dimension of 0.2 ϫ 0.2 ϫ 0.4 mm 3 after 7-10 days at 4°C with a hexagonal bipyramid shape. All experiments were carried out at 4°C to avoid proteolytic hydrolysis of the enzyme. Nevertheless, it was discovered at a later stage of structure determination that the full-length hTrpRS was cleaved into two fragments during crystallization. SDS-PAGE analysis indicates that the full-length hTrpRS was completely hydrolyzed into a large fragment of 42 kDa and a small fragment of 10 kDa in crystallization solution in 2 weeks (Fig. 1a) . However, the crystals contained both the full-length and the large fragment of hTrpRS with a ratio of ϳ1:3. The N terminus sequence of the large fragment was determined with the Edman degradation method using an ABI model 491A sequencer. The results indicate that the cleavage site is between positions 93 and 94, and the large fragment is equivalent to T2-hTrpRS. Therefore, we designate this structure T2-hTrpRS hereafter.
There are two potential sources to cause the hydrolysis of the fulllength enzyme. One possibility is that hTrpRS possesses a self-hydrolysis activity, and another is that a trace of protease impurity from the expression system digests the full-length enzyme. Comparisons of the primary sequence and the three-dimensional structure of hTrpRS with these of various proteases showed that hTrpRS shares no conserved sequence motif(s) or structural similarity with any protease, suggesting that hTrpRS is unlikely to have a self-hydrolysis activity. On the other hand, the addition of a protease inhibitor mixture (Complete, EDTAfree tablet (Roche Applied Science), which inhibits efficiently serine and cysteine proteases) in the purification and preparation of protein sample prohibits the degradation of the full-length hTrpRS completely. Further experiments showed that phenylmethylsulfonyl fluoride, a commonly used serine protease inhibitor, can completely inhibit the hydrolysis of the full-length hTrpRS, suggesting that the cleavage of the full-length hTrpRS is caused by the mere trace of bacterial serine protease(s) in the protein sample. Currently, we are able to prepare the full-length hTrpRS by adding 0.5 mM phenylmethylsulfonyl fluoride in the purification and preparation of the protein sample and to grow the full-length hTrpRS crystals (Fig. 1b) .
Because only the cleaved hTrpRS fragments are active in the signal pathways of angiogenesis, the specific hydrolysis of the full-length hTrpRS into the active T2-hTrpRS form by serine protease might have potential physiological significance. There are many types of serine proteases in human cells. The biochemical data have shown that human leukocyte elastase (a serine protease) can hydrolyze both the full-length hTrpRS and hTyrRS into the angiogenically active T1-and T2-hTrpRS and mini-hTyrRS in vitro (13, 14) . It is possible that a serine protease in human cells, such as leukocyte elastase, hydrolyzes the full-length hTrpRS and hTyrRS into the angiogenically active fragments, and angiogenesis is regulated by the balance of signaling molecules with the opposing functions.
Diffraction Data Collection and Structure Determination and Refinement-Diffraction data were collected from crystals flash-cooled at 100 K. The cryo-protectant solution contains 5% glycerol (w/v) in the reservoir solution. The selenium-methionine MAD data were collected using beamline X12C at the National Synchrotron Light Source at Brookhaven National Laboratory (Upton, NY). The diffraction data were recorded on a Brandeis B4 CCD detector mounted on a Nonius axis goniometer. The native diffraction data used for structure refinement were collected using the F1 beamline at the Cornell High Energy Synchrotron Source and recorded on a QUANTUM4 2k ϫ 2k ADSC CCD detector. All of the data were processed and scaled together using the HKL2000 suite (23) . Analysis of the diffraction data indicates that crystals of T2-hTrpRS belong to hexagonal space group P6 5 22 with the unit cell dimensions a ϭ b ϭ 82.80 Å and c ϭ 263.74 Å. The statistics of the diffraction data are summarized in Table I . There is one T2-hTrpRS molecule/asymmetric unit, and the corresponding Matthews coefficient (V M ) (24) is 2.5 Å 3 /Da with a solvent content of 50.9%. Attempts to solve the structure of T2-hTrpRS using bTrpRS structure as a starting model with molecular replacement method were unsuccessful. The structure of T2-hTrpRS was solved using the MAD method implemented in the program SOLVE (25) . The automatic protocol in SOLVE revealed 10 selenium sites in the asymmetric unit, consistent with the later discovery that this structure comprises mainly T2-hTrpRS, which contains 10 methionine residues. The MAD phases were improved by statistical density modification including solvent flattening and histogram matching using the program RESOLVE (26) . The overall figure-of-merit at 3.0 Å resolution was increased from 0.47 to 0.59. The resulting electron density map was of very good quality and was used to build an initial model. The RESOLVE program successfully located several secondary structural elements and automatically built about 200 polyalanine residues. Superposition of the bTrpRS structure onto these partially traced secondary structural elements of hTrpRS, especially several long ␣-helices, showed a fairly good fit of bTrpRS with the MAD phased electron density map. Therefore, the bTrpRS structure was used as a reference to guide the initial model building.
Structure refinement was carried out using the program CNS (27) . At the early stage of structure refinement, the model was refined against reflections with a maximum-likelihood target using experimental phase probability distribution (28) . The phase constraints were released at the later stage of structure refinement. A bulk solvent correction was applied in all refinements. Although the crystal was a mixture of the full-length hTrpRS and T2-hTrpRS, there was no evident electron density for the N-terminal 93 residues in both 2mF o Ϫ DF c and mF o Ϫ DF c difference Fourier maps. Water molecules were not included in the model and refinement until the R factor decreased to below 26%. The structure model building was facilitated using the program O (29) .
RESULTS AND DISCUSSION
Structure Description-The crystal structure of T2-hTrpRS was determined at 2.5 Å resolution using the MAD method. Structure refinement of the final atomic model converged to an R factor of 24.5% and a free R factor of 29.6% to 2.5 Å resolution. In the final structure, the N-terminal five residues (residues 94 -98) and the region containing the conserved KMSKS motif (residues 347-353) are partially disordered and have very weak electron density. Other regions with high temperature factors and weak electron density are located at solventexposed surface areas, including segments 112-124, 381-390, and 466 -471. The final model contains full residues from 94 to 471. Statistics of the diffraction data and structure refinement are given in Table I . Fig. 2 shows a representative SIGMAAweighted 2mF o Ϫ DF c map at 2.5 Å resolution in the region containing the conserved HIGH motif at the active site.
The overall structure of T2-hTrpRS is illustrated in Fig. 3 . T2-hTrpRS is folded into three domains: an N-terminal domain, a catalytic domain, and a C-terminal ␣-helical domain. It forms a homodimer with its 2-fold axis coincident with the crystallographic 2-fold symmetry of the P6 5 22 space group. Although T2-hTrpRS shares low sequence homologies with bTrpRS (22% identity) and the closely related mini-hTyrRS (less than 18% identity) (17), the overall structures of these enzymes are strikingly similar (Figs. 3 and 5 ). Superpositions a Numbers in parentheses refer to the highest resolution shell.
of the overall structures of these enzymes reveal RMS deviation values of about 2 Å (Table II) . The N-terminal domain (residues 94 -153) is made of four ␣-helices (␣1Ј, ␣2Ј, ␣3Ј, and ␣4Ј) and two short ␤-strands (␤1Ј and ␤2Ј) (Figs. 3 and 5). It flanks on one side of the catalytic domain and has tight interactions primarily with ␣-helix ␣1 and ␤-strand ␤5 of the catalytic domain. In particular, the two short ␤-strands extend the ␤-sheet of the catalytic domain. Mini-hTyrRSs has a short N-terminal extension of about 30 residues to its catalytic domain that folds in a similar manner as the N-terminal 50 residues of T2-hTrpRS (17) .
The catalytic domain of T2-hTrpRS assumes a classic Rossmann fold (RF) and comprises the active sites for adenylation and acyl transfer. It is made of ␤-strands ␤1-␤5, ␣-helices ␣1-␣9, and the C-terminal ␣-helix ␣15 and ranges from residues 154 to 362 and from residues 453 to 471 (Figs. 3 and 5). The two highly conserved signature sequences, "HIGH" and "KMSKS" (corresponding to HVGH and KMSAS in hTrpRS), are located at each end of the RF but are brought close to each other in the tertiary structure by a marked twist of the fivestranded parallel ␤-sheet to form the adenine-nucleotide binding site (Figs. 3 and 4) .
Like other class I aaRSs, T2-hTrpRS contains connective polypeptide 1 (CP1) (30 -32) , which forms two ␣-helices (␣5 and ␣6) and separates the RF into two halves. CP1 of T2-hTrpRS is involved in dimer interface interactions and appears to play important roles in the formation of the entrance to the substrate-binding pocket and in the binding of tRNA acceptor arm (see later section). This is in agreement with biochemical data suggesting that CP1 participates in interaction with tRNA (33) (34) (35) and in editing of the reaction intermediate aminoacyl-AMP and/or the aminoacyl-tRNA (17, 36 -38) . Because hTrpRS has no known editing activity, its CP1 insertion is very short (32 residues) compared with other class I aaRSs such as isoleucyl-, valyl-, and leucyl-tRNA synthetases that have editing activities. The C terminus of hTrpRS and bTrpRS forms part of the catalytic domain; however, it adopts a different conformation. In bTrpRS structures, the C-terminal 30 residues form a straight long ␣-helix that flanks on one side of the RF. In the T2-TrpRS structure, although residues 454 -460 form an ␣-helix (␣15) that is superimposable with the N-terminal portion of the long ␣-helix in bTrpRS, the C-terminal 11 residues are completely unwound into a random coil and make a sharp 90°t urn at the junction, wrapping around the RF and pointing its C terminus toward the N-terminal domain (Fig. 3) . Structural analysis reveals that hTrpRS contains two insertions at residues 243-247 (␣4-␣5 connecting loop) and residues 290 -304 (helix ␣8) compared with bTrpRS. These two structural elements occupy the spatial position where the C-terminal portion of the long ␣-helix in bTrpRS takes, preventing the C-terminal portion of hTrpRS from adopting a straight long ␣-helical structure and forcing it to make a sharp turn in the middle.
The C-terminal ␣-helical domain is composed of a four-helix bundle (␣10 and ␣12-␣14) and one short ␣-helix (␣11), ranging from residues 363 to 452 (Figs. 3 and 5) . It flanks on top of the RF domain, connecting to the catalytic domain via the KMSAS motif. This domain contains the putative binding site for tRNA Trp anticodon arm. Compared with bTrpRS, T2-hTrpRS has a 10-residue insertion (residues 380 -390) between ␣-helices ␣10 and ␣12 that forms a short ␣-helix (␣11). This short ␣-helix is located on the tip of the helical domain and exposed to the solvent and appears to be involved in the binding of tRNA anticodon loop (see later section).
Dimer Interface-T2-hTrpRS forms a symmetric homodimer in the crystal structure. The monomer has dimensions of 61ϫ 47 ϫ 46 Å 3 ; the dimer has dimensions of 122 ϫ 47 ϫ 46 Å 3 . Solvent-accessible surface areas of the monomer and the dimer are 16592 and 31155 Å 2 , respectively. The dimer interface buries 1014 Å 2 solvent-accessible surface of each monomer, corresponding to about 6% of the surface area of the monomer. The dimer interface is formed between five ␣-helices (␣2, and ␣4 -␣7) of the RF domain from each monomer (Fig. 3) . The interface contacts consist of both strong hydrophilic (including hydrogen bonding and electrostatic) and hydrophobic interactions.
TABLE II Structural comparisons of different TrpRSs in relative to the closed form bTrpRS⅐TAM complex
Superposition for the RF domain includes residues A1-A14 and A32-A188 and their equivalents, which exclude helix ␣A and the KMSKScontaining loop. Superposition for the ␣-helical domain includes residues A208 -A288 and their equivalents. To get the rotation angle of the ␣-helical domain in relative to the RF domain, we superimpose firstly the RF domain of each structure onto that of the bTrpRS⅐TAM complex and then superimpose the ␣-helical domain to yield a relative rotation matrix of the ␣-helical domain from which we compute the Lattman angles (ϩ and 2) and spherical angle (). The reference structure (bTrpRS⅐TAM) was oriented such that the long axis of the molecule is aligned with the y axis, the short axis is along the x axis, and the entrance of the active site pocket is towards the z axis. In this arrangement, Lattman angle ϩ represents approximately the rotation along the z axis, and 2 represents the rotation along the y axis; spherical angle () represents the overall rotation along the spherical axis. Positive angle is defined as rotation anti-clockwise, and negative angle is defined as rotation clockwise.
Protein Data Bank code State Compared with bTrpRS, T2-hTrpRS has a more globular shape, attributed to the N-terminal extension, an insertion (residues 293-303) in the RF domain, and a different conformation of the C terminus. The intersubunit relationship in the T2-hTrpRS dimer is more similar to bTrpRS than to hTyrRS, which is similar to bacterial TyrRSs. If we superimpose one subunit between T2-hTrpRS and hTyrRS, the other subunit can be superimposed by a 32°rotation. Because the structural elements forming the dimer interface are involved in tRNA binding, the different intersubunit relationship between TrpRSs and TyrRSs might imply that these enzymes interact with their cognate tRNA differently (see "Discussion").
Structure of the Catalytic Active Site-The catalytic active site is located at a deep cleft in the RF domain that is exposed to solvent and accessible to substrates. The catalytic active site consists of the ATP-binding subsite and the Trp-binding subsite. Based on the structures of bTrpRS in complexes with ATP, Trp, and TAM, we modeled the ATP and Trp substrates into the active site of the T2-hTrpRS structure. This permits us to discuss the potential functional roles of specific residues involved in substrate binding and in the aminoacylation mechanism.
The ATP-binding subsite is composed of several residues from the three conserved "HVGH" (␣1), "AIDQ" (␣9), and "KM-SAS" motifs and their neighboring structural elements (Fig. 4) . The docking experiments indicate that only conformational changes of amino acid side chains in the pocket would not be sufficient to form a high affinity binding pocket for ATP such as that observed in the structure of bTrpRS⅐TAM complex. The structural segment containing the KMSAS motif together with the ␣-helical domain will have to move closer to the bulk of RF to make appropriate interactions with ATP and to position ATP in the vicinity of Trp (the average distance of the movement for the KMSAS loop is about 3 Å). Thus, it is expected that the KMSAS-containing loop and the ␣-helical domain will undertake moderate conformational changes upon ATP binding. This is consistent with the substrate-induced conformational changes of the substrate-binding pocket in bTrpRS and TyrRS (21, 39) . In bTrpRS structures, the displacement of the KMSKS motif is about 4 -6 Å between the open and closed conformers (20 
. hTrpRS May Use Different Types of Residues to Recognize
Trp from bTrpRS-Recognition of the correct amino acid by aaRS is fundamental to the fidelity of protein synthesis. Because both bacterial and eukaryotic TrpRSs use ATP and Trp as their substrates, species specificity and efficiency would primarily rely on the differences in the sequence and structure of the enzymes and their specific interactions with Trp. Analysis of differences of these interactions might provide useful information about species specificity and efficiency that could be exploited in the design of efficient and specific antibacterial drugs.
In the bTrpRS structure, residues 122-133 form an ␣-helix that is designated as the "specificity determining helix" because several residues from this helix (especially Tyr 125 , Met 129 , and Asp 132 ) are involved in binding Trp (19, 21, 40) . Although this structural element is highly conserved and the residues implicated in specificity are superimposable between bTrpRS and hTrpRS, the types of these residues and their interactions with Trp differ substantially.
Tyr 125 of bTrpRS is located at the entrance to the Trpbinding subsite and is suggested to serve as a gate guard controlling the access to the pocket through alteration of its side chain (21 (19, 21) . This residue is highly conserved across all bacterial TrpRSs. However, the equivalent position in hTrpRS is Pro 287 , which is well conserved in most eukaryotic TrpRSs (12 (19) . It should be noted, however, that the side chain of Tyr 159 in this ligand-free T2-hTrpRS structure has moderate steric conflict with the docked Trp substrate. It is expected that the Tyr 159 side chain will alter its orientation slightly or the Trp substrate will take a slightly different position in the substrate-bound complex structure.
In addition, Gln 194 of hTrpRS appears to be also involved in determining the substrate specificity because its side chain interacts with both the indole group of Trp and the hydroxyl group of Tyr 159 via hydrogen bonds. The equivalent residue in bTrpRS is Cys 38 , which has no close contact with Trp. Moreover, the side chain of Gln 313 also makes a hydrogen bonding interaction with the amide group of the docked Trp. A similar interaction exists in the bTrpRS⅐TAM structure (19) .
The biological implication of the differences in the structures FIG. 5 . A, structure-based sequence alignment of hTrpRS with bTrpRS and the closely related TyrRSs with known structures. The sequence alignments were firstly generated using the program ClustalW (51) and then manually adjusted based on structural comparisons. The N-terminal 93 residues of hTrpRS are not present in this structure. The C-terminal sequences in bTrpRS and TyrRSs after that equivalent to residue 471 of and interactions at the Trp-binding subsite among hTrpRS and bTrpRS is very intriguing. Because eukaryotic TrpRSs are highly conserved in the Trp-binding subsite (12) , these differences might suggest that eukaryotic TrpRSs employ a different mechanism to recognize and interact with the Trp substrate than their bacterial orthologs. We propose that the primary specificity determinants in hTrpRS are Gln 284 (20) , and the typical closed conformer is the bTrpRS⅐TAM complex structure (19) . Compared with the closed conformer, the ␣-helical domain in the open conformer rotates about 13°away from the bulk of the RF domain, bringing the N-terminal ␣A helix and the two signature sequences (TIGH and KMSKS) outwards by 4 -6 Å in a concerted movement (20) . Conformations of bTrpRS structures are suggested to be related to catalysis and to represent different intermediate states of the enzyme in the reaction profile (20, 21) . Detailed comparisons of different TrpRS structures indicate that the conformational change of the ␣-helical domain among these structures can be decomposed into two components: a rotation along the long axis of the molecule (y axis) and a rotation along the axis vertical to the interface between the ␣-helical domain and the RF domain (z axis) (Fig. 5B and Table II ). The conformations of the ␣-helical domain in different bTrpRS structures can be grouped into three types: the closed conformer, the open conformer, and the pretransition state conformer. The open conformer differs from the closed conformer primarily by a rotation of about 13.5°anti-clockwise along the z axis; the pretransition state conformer differs by a rotation of about 10°clockwise along the y axis. Surprisingly, the unliganded T2-hTrpRS structure assumes a compact conformation that is more similar to the closed conformer of bTrpRS than to the open or pretransition state conformers (Fig. 5B and Table II ). The conformational difference of the ␣-helical domain between T2-hTrpRS and the bTrpRS⅐TAM complex is a 8.6°rotation anti-clockwise along the y axis.
Although T2-hTrpRS adopts a compact conformation, the entrance to the substrate-binding pocket in T2-hTrpRS is much wider than that in both the open and closed conformers of bTrpRS (Fig. 6) . The closest C␣-C␣ distance at the rim of the   FIG. 6. Molecular surfaces of T2-hTrpRS (a), the open form bTrpRS⅐ATP complex (b), and the closed form bTrpRS⅐TAM complex  (c) viewing from entrance (from the KMSKS-containing loop to the structural element at the opposite edge, the ␣6-␣7 connecting loop) is about 19 Å in T2-hTrpRS. The entrance is so broad that both ATP and Trp can enter the pocket simultaneously. In comparison, bTrpRS has a six-residue insertion (residues 108 -113) that forms part of an ␣-helix on the rim of the entrance at the opposite edge of the KMSKS-containing loop. This ␣-helix covers the top of the substrate-binding site and significantly narrows the opening of the entrance (the closest C␣-C␣ distance at the rim of the entrance is about 16 Å in the open form bTrpRS structures and 11 Å in the closed form bTrpRS structures, respectively). Because the structural element at the entrance of the pocket is suggested to play important role(s) in controlling ligand binding and in recognition of the tRNA acceptor stem (see later section), the difference in the width of the entrance between bacterial and mammalian TrpRSs might have important biological implications in the formation of the substratebinding pocket and in the binding of tRNA. This difference could partially explain the conformational differences of these enzymes in the ligand-free structures. Because hTrpRS has a wide entrance to the substrate-binding pocket, the KMSKScontaining loop and the ␣-helical domain do not need to expand outwards when ATP and/or Trp bind. In bTrpRS, the entrance to the substrate-binding pocket is narrowed by the extra structural element at the rim of the entrance. The KMSKS-containing loop and the ␣-helical domain have to open up to allow substrate binding to the pocket in the open conformer and close down to interact with the substrates in the closed conformer.
Putative Structural Determinants for tRNA Trp Binding-To date, there is no reported structure of TrpRS from any species in complex with tRNA Trp . However, the recently reported structure of tTyrRS (a close homolog of TrpRS) in complex with its cognate tRNA Tyr (41) enables us to dock a human tRNA Trp model into the T2-hTrpRS structure (Fig. 7) . Analysis of the interactions of the docked tRNA Trp with T2-hTrpRS permits us to postulate the structural determinants of hTrpRS responsible for tRNA binding and the identity elements of tRNA Trp responsible for specificity and anticodon interaction.
tTyrRS forms a symmetric homodimer in the crystal structure, and the tRNA binds across the two subunits of the dimeric enzyme (41) . The recognition mode of the class I tTyrRS for its cognate tRNA resembles that of the class II synthetase by interacting with the acceptor stem from the major groove (41) . Our docking experiments suggest that tRNA Trp binds with the dimeric hTrpRS and will interact with hTrpRS in a mode similar to that of tRNA Tyr with tTyrRS (Fig. 7) . Nonetheless, because of structural differences between tTyrRS and hTrpRS, the structural elements involved in recognition of tRNA appear to vary between the two enzymes.
In the structure of tTyrRS⅐tRNA complex, the interactions of tTyrRS with tRNA involve all three domains: the RF domain, the ␣-helical domain, and the unique C-terminal domain (41) . The C-terminal domain interacts with the characteristic long variable arm and the anticodon arm of tRNA Tyr . These interactions will not present in the hTrpRS⅐tRNA complex because of the absence of an equivalent C-terminal domain in TrpRS and an equivalent long variable arm in tRNA Trp . The interactions between tRNA Trp and hTrpRS appear to involve primarily the acceptor arm and the anticodon loop of tRNA and their corresponding recognition sites in hTrpRS.
In the tTyrRS⅐tRNA complex, the tRNA acceptor arm binds across the dimer interface onto the active site of the opposite subunit and the structural elements responsible for the recognition of the acceptor arm consists primarily of two segments of the RF domain: residues 148 -154 (helix ␣8) and residues 198 -211 (helix ␣11) (41). These segments correspond to residues 259 -265 (␣6) and residues 301-307 (␣9) in T2-hTrpRS, respectively. In the docked T2-hTrpRS⅐tRNA model, only helix ␣6 interacts with tRNA, whereas helix ␣9 does not. Instead, the ␣6-␣7 connecting loop (residues 266 -275) makes close contacts with the identity elements of human tRNA Trp , specifically the major element G73 and the minor elements G1/C72 and U5/ G68 (the equivalent elements are G73, A1/U72 and G5/C68 for prokaryotic tRNA
Trp in E. coli and Bacillus subtilis (12, 42) ). The differences appear to arise mainly from two factors. One is the marked difference in the subunit-subunit relationship at the dimer interface, which causes slight rearrangement of the structural elements involved in dimer interface formation. If we superimpose one subunit between tTyrRS and T2-hTrpRS together, the orientation of the other subunit differs by a 56°r otation. In the dimeric T2-hTrpRS, helix ␣9 is positioned below helix ␣6 and is too far to interact with the tRNA. The other factor is the structural difference at the rim of the entrance to the substrate-binding pocket between hTrpRS and tTyrRS (and other bacterial TyrRSs). tTyrRS (and other bacterial TyrRSs) contains a six-residue insertion (residues 158 -163) that forms part of a short ␣-helix C-terminal to helix ␣8 compared with hTrpRS (corresponding to the ␣6-␣7 connecting loop in T2-hTrpRS). Moreover, next to this inserted ␣-helix on the inner side of the pocket, tTyrRS (and other bacterial TyrRSs) have a nine-residue insertion (residues 85-93) that forms a ␤-turn. The presence of this ␤-turn prevents the inserted short ␣-helix from folding down over the substratebinding pocket and instead pushes it to protrude on the surface. Thus, the short ␣-helix becomes a barrier above the dimer interface to prevent the tRNA acceptor stem from passing through the first TyrRS molecule and landing its 3Ј end at the active site of the opposite subunit. To circumvent this barrier, the tRNA molecule moves outwards away from the tTyrRS molecule and consequently makes contacts with helices ␣8 and ␣11 of the opposite tTyrRS molecule. Because of the absence of the two insertions, the ␣6 helix and the ␣6-␣7 connecting loop in T2-hTrpRS fold down on top of the substrate-binding pocket and, together with the same structural elements of the opposite subunit, form a flat platform to interact with the acceptor stem of the tRNA. In this binding manner, tRNA is in a much closer position to the enzyme. Although bTrpRS also contains a sixresidue ␣-helix insertion (residues 108 -113) in the region equivalent to the ␣6-␣7 connecting loop of hTrpRS, this short ␣-helix folds down in a similar way as that of the ␣6-␣7 connecting loop because of the lack of the unique ␤-turn insertion in bacterial TyrRSs. Hence, it seems likely that bTrpRS (and other bacterial TrpRSs) might bind the tRNA acceptor arm in a similar way as that of hTrpRS. This is in agreement with the suggestion that residues 107-119 of bTrpRS is the acceptor stem recognition site (19) .
The anticodon triplet of tRNA interacts primarily with structural elements ␣12 and its C-terminal loop, the ␣14-␣15 loop, and ␣17 (which is absent in TrpRSs) in the tTyrRS⅐tRNA complex (41) . In the T2-hTrpRS⅐tRNA model, helix ␣10 and the ␣10-␣11 connecting loop (residues 367-384) (the equivalent of ␣12 and its C-terminal loop in tTyrRS) make extensive interactions with the anticodon bases C34, C35, and A36. In particular, the ␣10-␣11 connecting loop wraps around the anticodon triplet and appears to play an important role in tRNA anticodon recognition. The ␣13-␣14 connecting loop (residues 425-428; the equivalent of the ␣14-␣15 loop in tTyrRS) appears to make a secondary contribution to the interactions. The Nterminal domain in the present structure does not have any contact with the docked tRNA. However, because the N-terminal domain is in the vicinity of the ␣-helical domain and the RF domain, it is plausible that a complete N-terminal domain might have some interactions with tRNA.
According to the docked tRNA model, the regions responsible for anticodon recognition in bTrpRS correspond to residues 212-226 and 263-266. In bTrpRS the region equivalent to the ␣10-␣11 connecting loop of hTrpRS is much shorter and adopts a slightly different conformation because of the absence of helix ␣11. This loop appears to make moderate contacts with the anticodon base A36. This is consistent with the suggestion that residues 223-227 of bTrpRS are primarily involved in tRNA anticodon recognition (19) .
Putative Angiostatic Activity Site-Fragments of hTyrRS and hTrpRS are found to be active in angiogenesis signaling pathways, whereas the full-length enzymes are inactive (13, 14, 16, 43, 44) . Like CXC-chemokines, the activities of these angiogenesis regulators are correlated to the presence or absence of an ELR motif (45, 46) . Mini-hTyrRS that contains an ELR motif has the angiogenic activity, whereas hTrpRS fragments that lack an ELR motif have antiangiogenic activity. Structural and biochemical studies suggest that the angiogenic activity of mini-hTyrRS depends on the ELR motif in the catalytic domain, and the C-terminal domain appears to mask the ELR motif, preventing it from binding by receptor (17) . By analogy, it is suggested that the structural element(s) responsible for the angiostatic activity of hTrpRS is also located in the RF domain, and removal of the N-terminal domain may regulate the angiogenic activity by revealing a potential angiogenesis site that is inaccessible in full-length hTrpRS (13, 14) . However, there is no any biochemical and structural evidence. The crystal structure of T2-hTrpRS provides us with a structural basis for speculating about the potential angiogenesis site(s) of hTrpRS.
In the T2-hTrpRS structure, the existing N-terminal domain flanks on one side of the catalytic domain, and its N terminus extends toward and interacts with part of the C-terminal helical domain. Because the crystal is a mixture of T2-hTrpRS and full-length hTrpRS, the crystal packing in the lattice should be able to accommodate the complete N-terminal domain. In addition, because the aminoacylation activity of hTrpRS does not require the cleavage of the N-terminal domain, the potential spatial position of the N-terminal domain should not cover up the catalytic active site and/or the structural elements that form the active site (such as the KMSKS-containing loop) and/or interact with tRNA (such as helix ␣6 and the ␣6-␣7 connecting loop). Moreover, the missing N-terminal portion of the N-terminal domain should presumably fold with the existing part as a relatively compact domain, instead of two separate domains. Taking these considerations into account, it is possible that the missing N-terminal portion extends along the direction of the N terminus in T2-hTrpRS and folds between the helical domain and the existing N-terminal domain. In this spatial arrangement, the N-terminal domain would have contacts with several structural elements of the helical domain (␣-helices ␣11-␣13 and a short 3 10 helix 3) and several structural elements of the existing N-terminal portion (␣-helices ␣1Ј-␣3Ј). All of these structural elements that might be masked by the missing N-terminal domain could be potential candidates involved in receptor binding and signaling. However, based on the observations detailed below, we postulate that the angiostatic activity site of hTrpRS might be located at the C-terminal helical domain.
Structural and biochemical studies have shown that all members of the hematopoietic cytokine family share a common four-helical bundle topology, even though there is little discernible sequence identity among them (47-50). The receptors for hematopoietic growth factors belong to a large family of structurally related molecules comprising two or more immunoglobulin-like modules and also show little sequence identity among them. The receptor-binding surfaces of the cytokines vary substantially and have to complement to the receptor domain (see reviews in Refs. 48 -50) . Structural comparisons suggest that the C-terminal helical domain of hTrpRS appears to resemble the short chain cytokines, and the four helices of the helical domain can be superimposed onto that of the short chain cytokines reasonably well. The anatomy and connectivity of the four helices in hTrpRS, however, differ from those observed in the short chain helical cytokines. In considering of the remarkable variations in primary sequences and structures among different hematopoietic cytokines and their receptors, it is possible that the C-terminal helical domain of hTrpRS might represent a variant of the helical cytokine folds.
Nevertheless, we cannot exclude the possibility that the missing N-terminal domain might form a separate domain that connects to the bulk of the protein via a flexible linker and packs with a potential angiostatic activity site in the RF domain (43) . It is also plausible that removal of the N-terminal portion of hTrpRS might cause subtle, yet important rearrangement of the structure that subsequently creates conformational changes of structural elements that are not in the vicinity of the N-terminal domain. These structural elements, especially these exposed on the surface, could also be a potential angiostatic activity site. Structural studies of the fulllength hTrpRS and hTrpRS fragments in complexes with the potential receptor will eventually resolve this question and uncover the specific residues involved in angiostatic activity.
